The effects in vitro of 1-(1-phenylcyclohexyl) piperidine hydrochloride (sernyl) on oxidation by liver homogenates and mitochondria of rat☆
-
Add time:08/29/2019 Source:sciencedirect.com
A study of the effects in vitro of 1-(1-phenylcyclohexyl)piperidine·HCl (Sernyl) has shown that with succinate, α-ketoglutarate, β-hydroxybutyrate, or citrate as the substrate, the oxygen uptake by homogenates of rat liver was stimulated by 0·2 and 0·5 mM concentrations of the drug. Experiments with mitochondria gave similar results with succinate and α-ketoglutarate. Using the first three substrates or ferrocytochrome c, oxidative phosphorylation was uncoupled slightly by 0·1 mM and more markedly by 0·5 mM Sernyl. Mitochondrial swelling in 0·125 M KCl-0·02 M Tris: HCl buffer, pH 7·4, was enhanced by 0·1 mM Sernyl.A comparison of the effects of some analogs of the drug on the oxidation of succinate by liver homogenates showed that N-ethyl-1-cyclohexylcyclohexylamine·HCl and N-ethyl-1-phenylcyclohexylamine·HCl also had a stimulatory effect but less than that of Sernyl. No significant effect was shown by N-ethylcyclohexylamine·HCl, N-ethylpiperidine·HCl, or N-cyclohexylpiperidine·HCl.
We also recommend Trading Suppliers and Manufacturers of 1-(1-phenylcyclohexyl)-2,3-dihydro-4-pyridone (cas 113812-31-0). Pls Click Website Link as below: cas 113812-31-0 suppliers
Prev:The effects of 1-(1-Phenylcyclohexyl) piperidine HCl (Sernylan) on bulbospinal and spinal reflexes
Next:Synthesis and biological evaluation of aminobenzimidazole derivatives with a phenylcyclohexyl acetic acid group as anti-obesity and anti-diabetic agents) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Synthesis and biological evaluation of aminobenzimidazole derivatives with a phenylcyclohexyl acetic acid group as anti-obesity and anti-diabetic agents08/30/2019
- The effects of 1-(1-Phenylcyclohexyl) piperidine HCl (Sernylan) on bulbospinal and spinal reflexes08/28/2019
- Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor08/27/2019
- Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor08/26/2019
- Use of fission yeast heterologously expressing human cytochrome P450 2B6 in biotechnological synthesis of the designer drug metabolite N-(1-phenylcyclohexyl)-2-hydroxyethanamine08/25/2019
- Metabolism and toxicological detection of a new designer drug, N-(1-phenylcyclohexyl)propanamine, in rat urine using gas chromatography–mass spectrometry☆08/24/2019
- Metabolism and toxicological detection of the designer drug N-(1-phenylcyclohexyl)-3-methoxypropanamine (PCMPA) in rat urine using gas chromatography–mass spectrometry08/23/2019
- Investigations on the cytochrome P450 (CYP) isoenzymes involved in the metabolism of the designer drugs N-(1-phenyl cyclohexyl)-2-ethoxyethanamine and N-(1-phenylcyclohexyl)-2-methoxyethanamine08/22/2019


